Philadelphia, PA · Founded 2019 · Privately Held (backing)
Developer of a genetic medicines precision delivery platform intended to treat hematologic malignancies. Interius BioTherapeutics is based in Philadelphia, PA and was founded in 2019. It was valued at $350 million at a merger or acquisition in Oct 2025, the last priced event on record. It has raised $170 million across 4 recorded rounds; the latest was a $51.4 million later-stage round in May 2024.
PMV mark · valuation
$350.0M
Oct 2026
Priced at
a merger or acquisition
Oct 2025
Total raised
$169.6M
Last round
Later Stage VC
May 2024
Team — not yet on record
No current team members for Interius BioTherapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Interius BioTherapeutics with a free account
·The complete investor list: 20 names
·Watch Interius BioTherapeutics: the Monday email on marks, rounds and moves
